【24h】

Tadalafil and purpura.

机译:他达拉非和紫癜。

获取原文
获取原文并翻译 | 示例
           

摘要

Cutaneous and mucocutaneous eruptions are the most common drug adverse reactions [1,2]. Phos-phodiesterase type 5 (PDE5) inhibitors are commonly used for the treatment of erectile dysfunction, and since 2006, tadalafil has been in the European market.We describe a 65-year-old male who was attended for a 2-day history of non-pruritic palpable purpuric rash of the lower extremities (Figure 1) without fever, arthralgias, or malaise. Questioning revealed the intake of 20 mg of tadalafil (Cialis) 2 days prior, as prescribed by his urologist, because of erectile dysfunction. This was the first time that the patient had taken tadalafil or any other PDE5 inhibitor.
机译:皮肤和粘膜皮疹是最常见的药物不良反应[1,2]。磷酸二酯酶5型(PDE5)抑制剂通常用于治疗勃起功能障碍,自2006年以来,他达拉非进入欧洲市场。我们描述了一位65岁的男性,他曾接受过2天的勃起功能障碍治疗下肢无瘙痒性紫癜性皮疹(图1),无发热,关节痛或不适。询问显示,由于勃起功能障碍,按照他的泌尿科医师的处方,他达拉非(Cialis)在2天前摄入了20 mg。这是患者首次服用他达拉非或任何其他PDE5抑制剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号